Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion (scientific article)

scientific article

Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion is …

instance of (P31):

scholarly article

Q13442814

External links are

P356	DOI	10.1371/JOURNAL.PPAT.1000777
P3181	OpenCitations bibliographic resource ID	4475472
P932	PMC publication ID	2820536
P698	PubMed publication ID	20169190
P5875	ResearchGate publication ID	41487824

P2093

author name string

Arun George Paul

Bala Chandran

Neelam Sharma-Walia

Virginie Bottero

Nagaraj Kerur

Mohanan Valiya Veettil

Sathish Sadagopan

P2860

cites work

Prostaglandin E2 activates Ca2+ channels in bovine adrenal chromaffin cells

Q67912317

Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis

Q73784002

Anti-inflammatory drugs and their mechanism of action

Q77609041

IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells

Q81111357

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)

Q24650427

Gene expression profile of AIDS-related Kaposi's sarcoma

Q24797857

Angiogenesis in cancer and other diseases

Q27861015

Cyclooxygenase-2 expression in chronic hepatitis C and the effect of interferon alpha treatment

Q28221273

Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells

Q28221605

Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice

Q28262487

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

Q28299069

Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology

Q28300693

Molecular virology of Kaposi's sarcoma-associated herpesvirus

Q28363323

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

Q28363910

Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy

Q28577167

Rho and Rac take center stage

Q28645748

Cyclooxygenases: structural, cellular, and molecular biology

Q29616510

Rho GTPases and cell migration

Q29616714

Evidence of COX-1 and COX-2 expression in Kaposi's sarcoma tissues.

Q53334041

Kaposi's sarcoma-associated herpesvirus.

Q53947567

Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus

Q56794246

Comparative Evaluation of FGF-2–, VEGF-A–, and VEGF-C–Induced Angiogenesis, Lymphangiogenesis, Vascular Fenestrations, and Permeability

Q57382107

Prostaglandin E2Induction of Binding Activity to CRE and AP-2 Elements in Human T Lymphocytes

Q58052224

Pirated genes in Kaposi's sarcoma

Q60085824

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

Q29618605

Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway

Q30157749

Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.

Q33283844

Cox-2-selective inhibitors: the new super aspirins

Q33547609

Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway

Q33737793

A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus

Q33784966

Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.

Q33815241

Critical determinants of neoplastic angiogenesis.

Q33955072

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

Q34287766

Cyclooxygenase-2: a novel target for cancer chemotherapy?

Q34317347

A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.

Q34531461

Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer

Q34804039

Initiation of angiogenic Kaposi's sarcoma lesions

Q35057045

Prostaglandin E2 induces fibroblast growth factor 9 via EP3-dependent protein kinase Cdelta and Elk-1 signaling

Q35131505

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

Q35131811

Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest

Q35139294

The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia

Q35780951

Human herpesvirus 8 encodes a homolog of interleukin-6.

Q35876140

Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases

Q35914351

The role of prostaglandins and other eicosanoids in the gastrointestinal tract

Q36123763

Towards third generation matrix metalloproteinase inhibitors for cancer therapy

Q36421691

Novel functions of TIMPs in cell signaling

Q36471132

Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency

Q36540187

KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor

Q36591375

Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies

Q37009325

Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declin

Q37010247

KSHV infection and the pathogenesis of Kaposi's sarcoma

Q37014777

Prostaglandin E2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signaling

Q38362857

COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma

Q38435775

Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells

Q38521564

RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner

Q39321282

Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells

Q39877852

Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis

Q39892759

Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation

Q40002083

Kaposi's sarcoma herpes virus taps into a host microRNA regulatory network

Q40025792

Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications

Q40040603

Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP.

Q40060479

Prostanoids induce egr1 gene expression in cementoblastic OCCM cells

Q40087300

Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway

Q40146956

Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression

Q40173444

Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus

Q40218296

Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression

Q40267788

Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo

Q40287215

Connecting COX-2 and Wnt in cancer

Q40329613

Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.

Q40396797

Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma

Q40409082

The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.

Q40461940

Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2.

Q40502651

Cyclooxygenase-2 inhibitor nimesulide suppresses telomerase activity by blocking Akt/PKB activation in gastric cancer cell line

Q40525674

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements

Q40572745

Inflammatory cytokines inhibit Kaposi's sarcoma-associated herpesvirus lytic gene transcription in in vitro-infected endothelial cells

Q40589924

Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection

Q40598301

Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells

Q40598941

Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway

Q40636925

Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line

Q40694101

The restricted cellular host range of human herpesvirus 8.

Q40868542

Aetiology of Kaposi's sarcoma: current understanding and implications for therapy

Q41682881

Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts

Q41910302

EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway

Q41949634

Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions

Q42049779

Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases

Q42797828

ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection

Q42931199

Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines

Q43708447

Increased prostaglandin E2 and cAMP phosphodiesterase levels in Kaposi's sarcoma--a virus against host defense mechanism

Q43804595

Matrix metalloproteinases in the progression and regression of Kaposi's sarcoma

Q44053161

Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

Q44277985

Cyclooxygenase-2 inhibition improves macrophage function in melanoma and increases the antineoplastic activity of interferon gamma

Q44392696

Prostaglandin E2 activates Src signaling in lung adenocarcinoma cell via EP3.

Q45032023

Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.

Q45399853

Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.

Q45729612

Design and cloning of lentiviral vectors expressing small interfering RNAs

Q46412641

Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites.

Q46560423

Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids

Q46805111

P275

Creative Commons Attribution 4.0 International

copyrighted

issue

language of work or name

English

Q1860

P921

main subject

angiogenesis

Kaposi's sarcoma

inflammation

page(s)

e1000777

P577

publication date

2010-02-12

P1433

published in

PLOS Pathogens

Q283209

P1476

title

Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion

P478

volume

Reverse relations

cites work (P2860)

Q36415707	A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis
Q38073761	AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV.
Q35861265	Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Q34541350	Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis
Q36336086	An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes
Q64102452	Arachidonic Acid Derived Lipid Mediators Influence Kaposi's Sarcoma-Associated Herpesvirus Infection and Pathogenesis
Q41840182	COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP.
Q35675995	Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK.
Q39327821	Classical swine fever virus NS5A protein localizes to endoplasmic reticulum and induces oxidative stress in vascular endothelial cells
Q39176686	Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines
Q42123554	Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells
Q88037600	Correlation study of chronic nonbacterial prostatitis with the levels of COX-2 and PGE2 in prostatic secretion
Q37644800	Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis
Q38097263	Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies
Q37057685	Emmprin and KSHV: new partners in viral cancer pathogenesis.
Q34845606	EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination
Q38611188	Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells
Q35315503	Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation
Q91760713	HACE1, an E3 Ubiquitin Protein Ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus Infection-Induced Oxidative Stress by Promoting Nrf2 Activity
Q28545016	Herpesviral G protein-coupled receptors activate NFAT to induce tumor formation via inhibiting the SERCA calcium ATPase
Q30406863	Herpesvirus Genome Recognition Induced Acetylation of Nuclear IFI16 Is Essential for Its Cytoplasmic Translocation, Inflammasome and IFN-β Responses
Q38802773	Hijacking GPCRs by viral pathogens and tumor
Q37867038	Horizontal gene transfers with or without cell fusions in all categories of the living matter
Q34130226	Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma
Q90308027	Human Herpesvirus 8 and Host-Cell Interaction: Long-Lasting Physiological Modifications, Inflammation and Related Chronic Diseases
Q24302985	IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection
Q37085828	Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer
Q37378867	Inflammatory stress and sarcomagenesis: a vicious interplay
Q34615002	Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system
Q39126546	Involvement of unfolded protein response, p53 and Akt in modulation of porcine reproductive and respiratory syndrome virus-mediated JNK activation
Q42562294	KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes
Q49363063	KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis.
Q26742030	KSHV-Mediated Angiogenesis in Tumor Progression
Q34644229	Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.
Q40046587	Kaposi sarcoma herpesvirus pathogenesis.
Q92376588	Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis
Q36487309	Kaposi's sarcoma and its associated herpesvirus
Q34426472	Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression
Q28388436	Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1
Q28396451	Kaposi's sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infection
Q24629364	Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cells
Q39792755	Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.
Q36023151	Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
Q39611761	Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle
Q34102739	Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes
Q33852054	Life without double-headed non-muscle myosin II motor proteins
Q38894472	Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells
Q26784376	Lipoxins: nature's way to resolve inflammation
Q57462211	Mast Cell Activation and KSHV Infection in Kaposi Sarcoma
Q54229820	Micro RNAs from DNA Viruses are Found Widely in Plasma in a Large Observational Human Population.
Q92238951	Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus
Q35158385	Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors
Q33624377	Modulation of chemokine activity by viruses.
Q35124404	Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis
Q34013830	Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication
Q33718186	NFAT and CREB Regulate Kaposi's Sarcoma-Associated Herpesvirus-Induced Cyclooxygenase 2 (COX-2)
Q34311582	Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus.
Q35853271	Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis
Q42045465	Phosphorylation and polyubiquitination of transforming growth factor beta-activated kinase 1 are necessary for activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor
Q33820704	Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen
Q39240333	Reactive oxygen species are induced by Kaposi's sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry.
Q38201237	Rho'ing in and out of cells: viral interactions with Rho GTPase signaling
Q39236102	Role of Modulator of Inflammation Cyclooxygenase-2 in Gammaherpesvirus Mediated Tumorigenesis
Q21135231	Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma
Q35066362	The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis
Q26767186	The Role of Gammaherpesviruses in Cancer Pathogenesis
Q37288834	The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells
Q26995410	The modulation of apoptosis by oncogenic viruses
Q38248404	The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma
Q38211082	The role of inflammation in sarcoma
Q64247511	Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis
Q58796905	Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics
Q37871527	Viruses as key regulators of angiogenesis
Q34569859	Widespread evidence of viral miRNAs targeting host pathways
Q34027122	c-Cbl-mediated selective virus-receptor translocations into lipid rafts regulate productive Kaposi's sarcoma-associated herpesvirus infection in endothelial cells.